Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.61 |
| ▸ | FDPS | P14324 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 4/20 | 0.56 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.56 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.56 |
| ▸ | ABAT | P80404 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | TTR | P02766 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29952908 | 1.00 | ALDH1A1 (0.68) | ALDH1A1TSHRAOX1FDPSHPGD | |
| SCHEMBL793813 | 0.84 | ALDH1A1 (0.68) | ALDH1A1TSHRAOX1FDPSHPGD | |
| SCHEMBL27963608 | 0.82 | ALDH1A1 (0.46) | ALDH1A1TSHRAOX1FDPSHPGD | |
| SCHEMBL27476042 | 0.82 | KMT2A (0.48) | ALDH1A1TSHRAOX1HPGDCYP1A2 | |
| 3,4-Dimethoxybenzaldehyde SCHEMBL5308959 | 0.81 | ALDH1A1 (1.00) | ALDH1A1TSHRAOX1FDPSHPGD | |
| 3,4-Dimethoxybenzaldehyde SCHEMBL25202 | 0.81 | ALDH1A1 (1.00) | ALDH1A1TSHRAOX1FDPSHPGD | |
| 3,4-Dimethoxybenzaldehyde SCHEMBL29364994 | 0.81 | ALDH1A1 (1.00) | ALDH1A1TSHRAOX1FDPSHPGD | |
| 3,4-Dimethoxybenzaldehyde SCHEMBL1330962 | 0.81 | ALDH1A1 (1.00) | ALDH1A1TSHRAOX1FDPSHPGD | |
| SCHEMBL31471675 | 0.80 | ALDH1A1 (0.50) | ALDH1A1TSHRAOX1FDPSHPGD | |
| SCHEMBL11001934 | 0.80 | KMT2A (0.47) | ALDH1A1TSHRAOX1HPGDCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 686 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110632207-B | Method for identifying mold based on volatile gas components and evolution trend thereof | 南京财经大学 | 2022-04-29 | — | — | CN | claimed |
| CN-110632207-A | Method for identifying mold based on volatile gas components and evolution trend thereof | 南京财经大学 | 2019-12-31 | — | — | CN | claimed |
| WO-2017182945-A1 | FLUORESCENT COMPOUNDS, PRODUCTION METHODS AND USES THEREOF | UNIVERSIDADE DE AVEIRO (PT) | 2017-10-26 | — | — | WO | claimed |
| CN-1589136-A | Pharmaceutical and cosmetic compositions containing aromatic aldehydes bearing oxygen-containing groups | CUTANIX CORP (US) | 2005-03-02 | — | — | CN | claimed |
| US-20030124157-A1 | Compositions containing aromatic aldehydes and their use in treatments | ALLERGAN, INC. | 2003-07-03 | — | — | US | claimed |
| CN-122010898-A | 4-Sulfamoyl benzene propionamide compounds, and preparation method and application thereof | 中山莱博瑞辰生物医药有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20260109674-A1 | ALLOSTERIC MODULATION OF MUSCARINIC ACETYLCHOLINE RECEPTOR EFFICACY | THE UNIVERSITY OF TOLEDO (US) | 2026-04-23 | — | — | US | disclosed |
| EP-4169575-B1 | CONDENSED RING COMPOUNDS THAT INHIBIT H-PGDS | SATO PHARMA (JP) | 2026-01-07 | — | — | EP | disclosed |
| EP-4665712-A1 | COMPOUNDS, THEIR COMPOSITION AND THEIR USE AS NEMATICIDES | Bhukhanwala, Komal (IN) | 2025-12-24 | — | — | EP | disclosed |
| US-20250326746-A1 | EIF4E INHIBITORS AND USES THEREOF | PIC Therapeutics, Inc. | 2025-10-23 | — | — | US | disclosed |
| US-20250295632-A1 | COMPOUNDS AND METHODS FOR TREATING FRIEDREICH'S ATAXIA | Design Therapeutics, Inc. | 2025-09-25 | — | — | US | disclosed |
| CN-115667259-B | Fused ring compounds for inhibiting H-PGDS | 佐藤制药株式会社 | 2025-06-17 | — | — | CN | disclosed |
| EP-0183054-A1 | Copper formazane compounds, process for their preparation and their use as dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-06-04 | — | — | EP | disclosed |
| EP-0135040-A1 | Copper complex formazan compounds, process for their preparation and their use as dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-03-27 | — | — | EP | disclosed |
| EP-0108924-A1 | Heavy metal-containing formazane dyestuffs, methods for their preparation and their use in the dyeing and printing of fibre materials | BAYER AG (DE) | 1984-05-23 | — | — | EP | disclosed |
| EP-0099721-A1 | Reactive metal formazan blue dye | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-02-01 | — | — | EP | disclosed |
| EP-0028787-B1 | COPPER-FORMAZANE COMPOUNDS, PROCESS FOR THEIR PRODUCTION, AND THEIR USE AS DYESTUFFS | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-05-11 | — | — | EP | disclosed |
| US-4370145-A | Copper formazan compounds, processes for their preparation and their use as dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-01-25 | — | — | US | disclosed |
| EP-0028787-A2 | Copper-formazane compounds, process for their production, and their use as dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-05-20 | — | — | EP | disclosed |
| US-4024274-A | Benzylamine derivatives and process for preparing them | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250326746-A1 | EIF4E INHIBITORS AND USES THEREOF | EIF4E, EIF4EBP1, EIF4A1 | ALDH1A1 4776/4885TSHR 4140/4885AOX1 4262/4885 |
| US-20030124157-A1 | Compositions containing aromatic aldehydes and their use in treatments | TYR, ALDH2, AOX1 | ALDH1A1 4/4885TSHR 4387/4885AOX1 3/4885 |
| US-20260109674-A1 | ALLOSTERIC MODULATION OF MUSCARINIC ACETYLCHOLINE RECEPTOR EFFICACY | CHRM5, CHRM3, CHRNA3 | ALDH1A1 2558/4885TSHR 98/4885AOX1 3011/4885 |
| US-20250295632-A1 | COMPOUNDS AND METHODS FOR TREATING FRIEDREICH'S ATAXIA | ATXN2, CLN6, ATXN2L | ALDH1A1 3096/4885TSHR 3784/4885AOX1 617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.